Sucampo Pharmaceuticals, Inc. (SCMP) Release: Preclinical Data For Lubiprostone And Unoprostone Isopropyl To Be Presented At Experimental Biology Conference 2014
4/27/2014 1:58:23 AM
BETHESDA, Md., April 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that preclinical data for lubiprostone and unoprostone isopropyl will be presented at the Experimental Biology Society 2014 Conference in San Diego, California.
Help employers find you! Check out all the jobs and post your resume.
comments powered by